Differentiation, differentiation/gene therapy and cancer

Pharmacology and Therapeutics

Volumn 73, Issue 1, 1997, Pages 51-65

  Scott, Robert E ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

AP1; multistep differentiation process; proliferation control; SV40 T antigen and carcinogenesis

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALPHA INTERFERON; CYTARABINE; RETINOIC ACID DERIVATIVE;

CANCER; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL DIFFERENTIATION; GENE THERAPY; HUMANS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL;

EID: 0031035671     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(96)00120-9     Document Type: Review

References (93)

1. Andreeff, M., Stone, R., Young, C., Tong, W., Ervin, T., Arthur, K., Salvia, B., Tafuri, A., Kolitz, J., Rifkind, R., Kufe, D. and Marks. P. (1990) Treatment of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) with hexamethylene bisacetamide (HMBA). Blood 76 (Suppl. 1): 996.
2. Asher, A. L., Mule, J. J., Kasid, A., Resifo, N. P., Salo, J. C., Reichert, C. M., Jaffe, G., Fendly, B., Kriegler, M. and Rosenberg, S. A. (1991) Murine tumor cells transduced with the gene for tumor necrosis factor-α: evidence for paracrine immune effects of tumor necrosis factor against tumors. J. Immunol. 146: 3227-3234.
3. Banerjee, D., Zhao, S. C., Li, M-X., Schweitzer, B. I., Mineishi, S. and Bertino, J. R. (1994) Gene therapy utilizing drug resistance genes: a review. Stem Cells 12: 378-385.
4. Bengal, E., Ransone, L., Scharfmann, R., Dwarki, V. J., Tapscott, S. J., Weintraub, H. and Verma, I. M. (1992) Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell 68: 507-519.
5. Bolla, M., Lefur, R., TonVan, J., Domenge, C., Badet, J. M., Koskas, Y. and Laplanche, A. (1994) Prevention of second primary tumors with etretinate in squamous cell carcinoma of the oral cavity and oropharynx: results of a multicentric double-blind randomized study. Eur. J. Cancer 30A: 767-772.
6. Borden, E. C., Lotan, R., Levens, D., Young, C. W. and Waxman, S. (1993) Meeting report: differentiation therapy of cancer: laboratory and clinical investigations. Cancer Res. 53: 4109-4115.
7. Byrne, C. and Fuchs, E. (1993) Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice. Mol. Cell. Biol. 13: 3176-3190.
8. Carter, R. L. (ed.) (1984) Precancerous States. Oxford Medical Publications, London, New York.
9. Castiagne, S., Chomuienne, C., Daniel, M. T., Ballerini, P., Berger, R., Fenaux, P. and Degos, L. (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76: 1704-1709.
10. Chen, Z-X., Xue, Y-Q., Zhang, R., Tao, R-F., Xia, X-M., Wang, W., Zu, W-Y., Yao, X-Z. and Ling, B-J. (1991) A clinical and experimental study on all-trans retinoic acid treated acute promyelocytic leukemia patients. Blood 78: 1413-1419.
11. Clark, R. E., Ismail, S. A. D., Jacobs, A., Payne, H. and Smith, S. A. (1987) A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome. Br. J. Haematol. 66: 77-83.
12. Cornetta, K., Morgan, R. A. and Anderson, W. F. (1991) Safety issues related to retro viral-mediated gene transfer in humans. Hum. Gene Ther. 2: 5-14.
13. Dean, A., Erard, F., Schneider, A. B. and Schechter, A. N. (1981) Induction of hemoglobin accumulation in human K562 cells by hemin is reversible. Science 212: 459-461.
14. Dinko, V., van Beusecham, V., van Bekkum, D., Boesen, J., Breemsn, D., Einerhand, M., van Es, H., Hoogerbrugge, P., Knaan, S., Lowenberg, B. and Ploemacher, R. (1996) Strategies aimed at improving transduction of primate hemopoietic stem cells. In: Gene Therapy for Hematopoietic Stem Cells in Genetic Disease and Cancer, Keystone Symposia on Molecular and Cellular Biology, Taos, New Mexico, p. 14, Keystone Symposium Publications, Keystone.
15. Donahue, R. E., Kessler, S. W., Bodine, D., McDonagh, K., Dunbar, C., Goodman, S., Agricola, B., Byrne, E., Raffeld, M., Moen, R., Bacher, J., Zsebo, K. M. and Nienhaus, A. W. (1992) Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176: 1125-1135.
16. Eisenhauer, E. A., Lippman, S. M., Kavanagh, J. J., Parades-Espinoza, M., Arnold., A., Hong, W. K., Massmini, G., Schleuniger, U., Bollag, W. and Holdener, E. E. (1994) Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors. Leukemia 8: 1622-1625.
17. El-Deiry, W. G., Tokino, T., Valculescu, V. E., Levy, D. B., Pasrons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
18. Ephrussi, A., Church, G. M., Tonegawa, S. and Gilbert, W. (1985) B lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 277: 134-139.
19. Estervig, D., Minoo, P., Tzen, C-Y. and Scott, R. E. (1990) Three distinct effects of SV40 T-antigen gene transfection on cellular differentiation. J. Cell. Physiol. 142: 552-558.
20. Fearon, E. R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
21. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83: 803-812.
22. Friend, C., Scher, W., Holland, J. G. and Sato, T. (1971) Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc. Natl. Acad. Sci. USA 68: 378-382.
23. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Cai, D. W., Owen-Schaub, L. B. and Roth, J. A. (1993) Retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res. 53: 4129-4133.
24. Fujiwara, T., Grimm, E. G. and Roth, J. A. (1994) Gene therapeutics and gene therapy for cancer. Curr. Opin. Oncol. 6: 96-105.
25. Georges, R. N., Mukhopadhyay, T., Zhang, Y., Yen, N. and Roth, J. A. (1993) Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense k-ras construct. Cancer Res. 53: 1743-1746.
26. Green, H. and Kehinde, O. (1975) An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5: 19-27.
27. Gutterman, J. U. (1994) Cytokine therapeutics: lessons from interferon α. Proc. Natl. Acad. Sci. USA 91: 1198-1205.
28. 1 cyclin-dependent kinases. Cell 75: 805-816.
29. 3 and retinoic acid in acute leukemia and myelodysplastic syndromes. Eur. J. Haematol. 40: 449-459.
30. Hoerl, B. J. and Scott, R. E. (1989) Nonterminally differentiated cells express decreased growth factor responsiveness. J. Cell. Physiol. 139: 68-75.
31. Holtzer, H. (1970) Proliferative and quantal cell cycles in the differentiation of muscle, cartilage, and red blood cells. Sym. Int. Soc. Cell Biol. 9: 69-83.
32. Hong, W. K., Endicott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., Toth, B. B., Kramer, A., Dimery, I. W., Skipper, P. and Strong, S. (1986) 13-cis-Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med. 24: 1501-1505.
33. Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., Dimery, I. W., Brown, B. W. and Goepfert, H. (1990) Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 12: 795-800.
34. Housset, M., Daniel, M. T. and Degos, L. (1982) Small doses of ARA-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells? Br. J. Haematol. 51: 125-129.
35. Jiang, H., Lin, J., Su, Z.-Z., Herlyn, M., Kerbel, R. S., Weissman, B. E., Welch, D. R. and Fisher, P. B. (1995) The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 10: 1855-1864.
36. Kerr, W. G. and Mule, J. J. (1994) Gene therapy: current status and future prospects. J. Leukoc. Biol. 56: 210-214.
37. Kmiec, R. B., Cole-Strauss, A., Xiang, Y-F., Byrne, B. C. and Gryn, J. (1996) Gene therapy for sickle cell anemia: genetic conversion of the single-base mutation. In: Gene Therapy for Hematopoietic Stem Cells in Genetic Disease and Cancer, Keystone Symposia on Molecular and Cellular Biology, Taos, New Mexico, p. 34, Keystone Symposium Publications, Keystone.
38. Knudson, A. G. and Meadows, A. T. (1978) Developmental genetics of neural tumors in man. In: Cell Differentiation and Neoplasia, pp. 83-92, Saunders, G. F. (ed.) Raven Press, New York.
39. 3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat. Rep. 69: 1399-1407.
40. Lee, J-H. and Klein, H. G. (1995) Cellular Gene Therapy. Transfus. Med. II 9: 91-113.
41. Lee, J. S., Newman, R. A., Lippman, S. A., Huber, M. H., Minor, M. N., Krakoff, I. H. and Hong, W. K. (1993) Phase I evaluation of all-trans-retinoic acid in adults with solid tumors. J. Clin. Oncol. 11: 959-966.
42. Lippman, S. M., Glisson, B. S., Kavanaugh, J. J., Lotan, R., Hong, W. K., Paredes-Espinoza, M., Hittelman, W. N., Holdener, E. E. and Krakoff, I. H. (1993) Retinoic acid and interferon combination studies in human cancer. Leuk. Res. 29A: 59-63.
43. Lippman, S. M., Donovan, T., Frankenthaler, R. A., Weber, R. S., Earley, C. L., Hong, W. K. and Goepfert, H. (1994) 13-cis-Retinoic acid plus interferon-α2a in recurrent respiratory papillomatosis. J. Natl. Cancer Inst. 86: 859-861.
44. Marks, P. A., Rifkind, R. A., Bank, A., Terada, M., Reuben, R., Fibach, E., Nudel, U., Salmon, J. and Gazitt, Y. (1978) Induction of differentiation of murine erythroleukemia cells. In: Cell Differentiation and Neoplasia, pp. 453-471, Saunders, G. F. (ed.) Raven Press, New York.
45. McKnight, S. L. and Yamamoto, K. R. (1992) CCAAT/enhancer binding protein. In: Transcriptional Regulation, pp. 771-795, McKnight, S. L. and Yamamoto, K. R. (eds.) Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
46. Mellibovsky, L., Diez, A., Aubia, J., Nogues, X., Perex-Vila, E., Serrano, S. and Recker, R. R. (1993) Long-standing remission after 25-OH D3 treatment in a case of chronic myelomonocytic leukaemia. Br. J. Haematol. 85: 811-812.
47. Meng-er, H., Yu-chen, Y., Shu-rong, C., Jin-ren, C., Jia-Xiang, L., Long-jun, J. and Zhen-yi, W. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567-572.
48. Minoo, P., Sullivan, W., Solomon, L. R., Martin, T. E., Toft, D. O. and Scott, R. E. (1989) Loss of proliferative potential during terminal differentiation coincides with the decreased abundance of a subset of hnRNP proteins. J. Cell Biol. 109: 1937-1946.
49. Pastorino, U., Infante, M., Maioli, M., Shiesa, G., Buyse, M., Firket, P., Rosmentz, N., Clerici, M., Soresi, E., Valente, M., Belloni, P. A. and Ravasi, G. (1993) Adjuvant treatment of state I lung cancer with high-dose vitamin A. J. Clin. Oncol. 7: 1216-1222.
50. Petti, M. C., Mandelli, F., Zagonel, V., DeGregoris, C., Merola, M. C., Latagliata, R., Gattei, V., Fazi, P., Monfardini, S. and Pinto, A. (1993) Pilot study of 5-aza-2′-deoxycytidine (Decitabine) in the treatment of poor prognosis acute myelogenous leukemia patients: preliminary results. Leukemia 7: 36-41.
51. Ponnazhagan, S., Nallari, M. L. and Srivasta, A. (1994) Suppression of human α-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors. J. Exp. Med. 179: 733-738.
52. Rheinwald, J. G. and Beckett, M. A. (1980) Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell 22: 629-632.
53. Rinaldi, D. A., Lippman, S. M., Burris, H. A., Chou, C., Von Hoff, D. D. and Hong, W. K. (1993) Phase II study of 13-cis-retinoic acid and interferon-α2a in patients with advanced squamous cell lung cancer. Anticancer Drugs 4: 33-36.
54. Rosenberg, S. A., Aebersold, P., Cornetta, K., Kasid, A., Margan, R. A., Moen, R., Karson, E. M., Lotze, M. T., Yang, J. C., Topalian, S. L., Merino, M. J., Culver, K., Miller, A. D., Blaese, R. M. and Anderson, W. F. (1990) Gene transfer into humans -immunotherapy of patients with advanced melanoma using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323: 570-578.
55. Rosenberg, S. A., Kasid, A., Anderson, W. F., Blaese, R. M. and Abersold, P. (1992) Gene therapy of patients with advanced cancer using tumor infiltrating lymphocytes transduced with the gene coding for tumor necrosis factor. Hum. Gene Ther. 3: 57-73.
56. Rosenberg, S. A., Anderson, W. F., Blaese, M., Hwu, P., Yannelli, J. R., Yang, J. C., Topalian, S. L., Schwartzentruber, D. J., Weber, J. S., Ettinghausen, S. E., Parkinson, D. N. and White, D. E. (1993) The development of gene therapy for the treatment of cancer. Ann. Surg. 218: 455-464.
57. Roth, A. D., Abele, R. and Albert, P. (1994) 13-cis-Retinoic acid plus interferon alpha: a phase II clinical study in squamous cell carcinoma of the lung and the head and neck. Oncology 51: 84-86.
58. Sachs, L. (1980) Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy. Proc. Natl. Acad. Sci. USA 77: 6152-6156.
59. Samulski, R. J. (1996) AAV vectors in vivo. In: Gene Therapy for Hematopoietic Stem Cells in Genetic Disease and Cancer, Keystone Symposia on Molecular and Cellular Biology, Taos, New Mexico, pp. 12-13, Keystone Symposium Publications, Keystone.
60. Schlaeger, T. M., Qin, Y., Fujiwara, Y., Magram, J. and Sato, T. N. (1995) Vascular endothelial cell lineage-specific promoter in transgenic mice. Development 121: 1089-1098.
61. Schule, R., Rangarajan, P., Kliewer, S., Ransone, L. J., Bolado, J., Yang, N., Verma, I. M. and Evans, R. M. (1990) Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62: 1217-1226.
62. Scott, R. E. (1995) The differentiation therapy of cancer: past, present, and future. Mol. Cell. Diff. 3: 157-173.
63. Scott, R. E. and Maercklein, P. B. (1985) An initiator of carcinogenesis selectively and stably inhibits stem cell differentiation: a concept that initiation of carcinogenesis involves multiple phases. Proc. Natl. Acad. Sci. USA 82: 2995-2999.
64. Scott, R. E., Hoerl, B. J., Wille, J. J., Jr., Florine, D. L., Krawisz, B. R. and Yun, K. (1982) Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation. J. Cell Biol. 94: 400-405.
65. 1 arrested 3T3T proadipocytes at the predifferentiation GD state and the growth-factor deficiency GS state. Exp. Cell Res. 143: 405-411.
66. Sell, S. (1993) The role of determined stem-cells in the cellular lineage of hepatocellular carcinoma. Int. J. Dev. Biol. 37: 189-201.
67. Smith, M. A., Parkinson, D. R., Cheson, B. D. and Friedman, M. A. (1992) Retinoids in cancer therapy. J. Clin. Oncol. 10: 839-864.
68. Sorrentino, B. P., Brandt, S. J., Bodine, D., Gottesman, M. M., Pastan, I., Cline, A. and Nienhuis, A. W. (1992) Retroviral transfer of the human MDR1 gene permits selection of drug resistant bone marrow cells in vivo. Science 257: 99-103.
69. Sparks, R. L., Estervig, D. N. and Scott, R. E. (1988) Differentiation and its role in carcinogenesis and anticarcinogenesis. In: Growth Factors, Tumor Promoters, and Cancer Genes, pp. 171-182, Colburn, N. H., Moses, H. L. and Stanbridge, E. J. (eds.) Alan R. Liss, Inc., New York.
70. Su, H., Lu, R., Chang, J. C. and Wai, Y. (1996) AAV mediated cell type specific promoter and enhancer regulated HSV-TK expression in hepatocellular carcinoma in vitro and in vivo. In: Gene Therapy for Hematopoietic Stem Cells in Genetic Disease and Cancer, Keystone Symposia on Molecular and Cellular Biology, Taos, New Mexico, p. 36, Keystone Symposium Publications, Keystone.
71. Tamm, I., Lin, S. L. and Pfeffer, L. M. (1987) Interferons α and β as cellular regulatory molecules. Interferon 9: 14-74.
72. Tilly, H., Castaigne, S., Bordessoule, D., Casassus, P., LePrise, P., Tertian, G., Desablens, B., Henry-Amar, M. and Degos, L. (1990) Low-dose cytarabine versus intensive chemotherapy in the treatment of nonlymphocytic leukemia in the elderly. J. Clin. Oncol. 8: 272-279.
73. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I. and Spiegelman, B. M. (1994) mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8: 1224-1234.
74. Vedantham, S., Gamliel, H. and Colomb, H. M. (1992) Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy. Cancer Res. 52: 1056-1066.
75. Wang, H. and Scott, R. E. (1991) Insulin-induced mitogenesis associated with transformation by the SV40 large T antigen. J. Cell. Physiol. 147: 102-110
76. Wang, H. and Scott, R. E. (1992) Induction of c-jun independent of PKC, pertussis toxin-sensitive G protein and polyamines in quiescent SV40-transformed 3T3T cells. Exp. Cell Res. 203: 47-55.
77. Wang, H. and Scott, R. E. (1994) Adipocyte differentiation selectively represses the serum inducibility of c-jun and jun-B by reversible transcription-dependent mechanisms. Proc. Natl. Acad. Sci. USA 91: 4649-4653.
78. Wang, H. and Scott, R. E. (1996) Differentiation modulates the balance of positive and negative Jun/AP1 activities to regulate cellular proliferative potential in different ways in non-transformed and transformed cells. J. Cell Biol., in press.
79. Wang, H., Wang, J-Y., Johnson, L. R. and Scott, R. E. (1991) Selective induction of c-jun and jun-B but not c-fos or c-myc during mitogenesis in SV40-transformed cells at the predifferentiation growth arrest state. Cell Growth Differ. 2: 645-652.
80. Warrell, R. P., Frankel, S. R., Miller, W. H., Scheingerg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., Gabrilove, J., Gordon, M. S. and Dmitrovsky, E. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoid (all-trans retinoic acid). N. Engl. J. Med. 20: 1385-1393.
81. Waxman, S. and Takaku, F. (1988) The incorporation of differentiation induction into the design of cancer therapy. In: The Status Of Differentiation Therapy Of Cancer, Vol. 45, pp. 407-419, Waxman, S., Rossi, G. B. and Takaku, F. (eds.) Serono Symposia Publications for Raven Press, New York.
82. Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., Blackwell, K., Turner, D., Rupp, R., Hollenberg, S., Zhuang, Y. and Lassar, A. (1991) The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251: 761-766.
83. Wier, M. L. and Scott, R. E. (1985) Defective control of terminal differentiation and its role in carcinogenesis in the 3T3 proadipocyte stem cell line. Cancer Res. 45: 3339-3346.
84. Wier, M. L. and Scott, R. E. (1986a) Regulation of the terminal event in cellular differentiation. Biological mechanisms of the loss of proliferative potential. J. Cell Biol. 102: 1955-1964.
85. Wier, M. L. and Scott, R. E. (1986b) Aproliferin: a human plasma protein that induces the irreversible loss of proliferative potential associated with terminal differentiation. Am. J. Pathol. 131: 546-554.
86. Wilke, M. S., Hsu, B. M., Wille, J. J., Pittelkow, M. R. and Scott, R. E. (1988) Biologic mechanism for the regulation of normal human keratinocyte proliferation and differentiation. Am. J. Pathol. 131: 171-181.
87. Wille, J. J., Jr. and Scott, R. E. (1986) Suppression of tumorigenicity by the cell-cycle-dependent control of cellular differentiation and proliferation. Int. J. Cancer 37: 875-881.
88. Wilson, J. (1996) "Opinion." The Scientist 10: 1-10.
89. Wisch, J. S., Griffin, J. D. and Kufe, D. W. (1983) Response of preleukemic syndromes to continuous infusion of low-dose cytarabine. N. Engl. J. Med. 309: 1599-1602.
90. Wu, R. L., Calvin, S., Wu, S. K., Xu, C., Blumenberg, M. and Sun, T. T. (1993) A 300 bp 5′-upstream sequence of a differentiation-dependent rabbit K3 keratin gene can serve as a keratinocyte-specific promoter. J. Cell Sci. 105: 303-316.
91. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R. and Beach, D. (1993) P21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
92. Yuspa, S. H. (1994) The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis - Thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Res. 54: 1178-1189.
93. Zhang, Y., Mukhopadhyay, T., Donehower, L. A., Georges, R. N. and Roth, J. A. (1993) Retroviral vector-mediated transduction of k-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype. Hum. Gene Ther. 4: 451-460.